Concord Drugs Limited (CONCORD.BO)
INR 30.97
(-1.05%)
INR 30.97
(-1.05%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 249.88 Million INR | -5.8% |
| 2022 | 265.26 Million INR | -5.55% |
| 2021 | 280.84 Million INR | 21.49% |
| 2020 | 231.16 Million INR | -33.06% |
| 2019 | 345.3 Million INR | -42.07% |
| 2018 | 596.12 Million INR | -31.55% |
| 2017 | 870.9 Million INR | 55.43% |
| 2016 | 560.33 Million INR | 50.44% |
| 2015 | 372.46 Million INR | -8.93% |
| 2014 | 408.98 Million INR | 35.83% |
| 2013 | 301.1 Million INR | 11.95% |
| 2012 | 268.95 Million INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | -338.17 Million INR | -235.33% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 257.63 Million INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 249.88 Million INR | 0.0% |
| 2023 FY | 249.88 Million INR | -5.8% |
| 2022 FY | 265.26 Million INR | -5.55% |
| 2022 Q2 | 251.64 Million INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 265.26 Million INR | 0.0% |
| 2021 Q2 | 236.82 Million INR | 0.0% |
| 2021 FY | 280.84 Million INR | 21.49% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q4 | 280.84 Million INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2020 Q2 | 392.99 Million INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 FY | 231.16 Million INR | -33.06% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q4 | 231.16 Million INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 FY | 345.3 Million INR | -42.07% |
| 2019 Q4 | 345.3 Million INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q2 | 497.55 Million INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q2 | 877.02 Million INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 FY | 596.12 Million INR | -31.55% |
| 2018 Q4 | 596.12 Million INR | 0.0% |
| 2017 Q4 | 870.9 Million INR | 0.0% |
| 2017 Q2 | 745.9 Million INR | 0.0% |
| 2017 Q1 | - INR | -100.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 FY | 870.9 Million INR | 55.43% |
| 2016 Q3 | - INR | -100.0% |
| 2016 FY | 560.33 Million INR | 50.44% |
| 2016 Q4 | 595.27 Million INR | 0.0% |
| 2016 Q2 | 488.07 Million INR | 0.0% |
| 2016 Q1 | - INR | -100.0% |
| 2015 Q3 | - INR | -100.0% |
| 2015 Q2 | 388.67 Million INR | 0.0% |
| 2015 Q1 | - INR | -100.0% |
| 2015 FY | 372.46 Million INR | -8.93% |
| 2015 Q4 | 371.16 Million INR | 0.0% |
| 2014 Q4 | 389.45 Million INR | 0.0% |
| 2014 Q2 | 275.51 Million INR | 0.0% |
| 2014 Q3 | - INR | -100.0% |
| 2014 FY | 408.98 Million INR | 35.83% |
| 2013 Q4 | 301.1 Million INR | 0.0% |
| 2013 FY | 301.1 Million INR | 11.95% |
| 2012 Q4 | 268.95 Million INR | 0.0% |
| 2012 FY | 268.95 Million INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| DECIPHER LABS LIMITED | 117.72 Million INR | -112.262% |
| Gujarat Themis Biosyn Limited | 197.37 Million INR | -26.606% |
| Ishita Drugs and Industries Limited | 8.87 Million INR | -2716.569% |
| MedPlus Health Services Limited | 14.27 Billion INR | 98.249% |
| ANG Lifesciences India Limited | 1.66 Billion INR | 84.961% |
| Add-Shop E-Retail Limited | 159.2 Million INR | -56.96% |
| Bacil Pharma Limited | 1.12 Million INR | -22033.392% |
| BDH Industries Limited | 312.53 Million INR | 20.045% |
| Beryl Drugs Limited | 85.63 Million INR | -191.8% |
| Cian Healthcare Limited | 1.03 Billion INR | 75.841% |
| Chemo Pharma Laboratories Limited | 2.12 Million INR | -11642.763% |
| Deccan Health Care Limited | 111.33 Million INR | -124.443% |
| Gujarat Terce Laboratories Limited | 161.67 Million INR | -54.562% |
| Hindustan Bio Sciences Limited | 25.7 Million INR | -872.279% |
| Jenburkt Pharmaceuticals Limited | 201.59 Million INR | -23.956% |
| KIMIA BIOSCIENCES LIMITED | 996.35 Million INR | 74.92% |
| Kwality Pharmaceuticals Limited | 1.71 Billion INR | 85.44% |
| Makers Laboratories Limited | 569.18 Million INR | 56.097% |
| Medi-Caps Limited | 63.01 Million INR | -296.544% |
| Panchsheel Organics Limited | 340.2 Million INR | 26.548% |
| Parmax Pharma Limited | 117.56 Million INR | -112.546% |
| Parnax Lab Limited | 1.17 Billion INR | 78.655% |
| Patidar Buildcon Limited | 25.57 Million INR | -877.186% |
| Phaarmasia Limited | 211.49 Million INR | -18.152% |
| Vikram Thermo (India) Limited | 291.47 Million INR | 14.269% |
| Sanjivani Paranteral Limited. | 155.06 Million INR | -61.149% |
| SHAMROCK INDUSTRIAL CO.LTD. | 299 Thousand INR | -83473.913% |
| Smruthi Organics Limited | 485.72 Million INR | 48.553% |
| Source Natural Foods and Herbal Supplements Limited | 41.97 Million INR | -495.364% |
| SUDARSHAN PHARMA INDUSTRIES LI | 1.71 Billion INR | 85.422% |
| Trident Lifeline Limited | 331.26 Million INR | 24.565% |
| Transchem Limited | 6.72 Million INR | -3618.542% |
| Trinity League India Limited | 876 Thousand INR | -28425.799% |
| Tyche Industries Limited | 101.64 Million INR | -145.852% |
| Vista Pharmaceuticals Limited | 175.16 Million INR | -42.656% |
| Vivanza Biosciences Limited | 148.63 Million INR | -68.125% |
| PRAVEG LIMITED | 767.53 Million INR | 67.443% |
| Sastasundar Ventures Limited | 1.5 Billion INR | 83.347% |
| Sunil Healthcare Limited | 902.83 Million INR | 72.322% |
| Syschem (India) Limited | 1.07 Billion INR | 76.662% |
| Zenith Healthcare Limited | 24.03 Million INR | -939.675% |
| Zenlabs Ethica Limited | 301.35 Million INR | 17.079% |
| Mercury Laboratories Limited | 171.18 Million INR | -45.971% |
| SHELTER PHARMA LIMITED | 20.99 Million INR | -1090.5% |
| Vasundhara Rasayans Limited | 53.64 Million INR | -365.797% |
| Bharat Immunologicals & Biologicals Corporation Limited | 1 Billion INR | 75.119% |
| Roopa Industries Limited | 493.08 Million INR | 49.322% |
| PANJON LTD. | 25.38 Million INR | -884.462% |
| Pharmaids Pharmaceuticals Limited | 208.44 Million INR | -19.883% |
| TIAAN CONSUMER LIMITED | 14.97 Million INR | -1568.242% |
| Anuh Pharma Limited | 1.54 Billion INR | 83.822% |
| Crestchem Limited | 23.94 Million INR | -943.496% |
| Emmessar Biotech & Nutrition Limited | 13.4 Million INR | -1764.125% |
| Sandu Pharmaceuticals Limited | 118.22 Million INR | -111.368% |
| Fredun Pharmaceuticals Limited | 1.86 Billion INR | 86.575% |
| Trimurthi Limited | 101.36 Thousand INR | -246433.149% |
| Shukra Pharmaceuticals Limited | 201.97 Million INR | -23.722% |
| Norris Medicines Limited | 278.17 Million INR | 10.169% |
| Veerhealth Care Limited | 62.78 Million INR | -298.034% |
| Lactose (India) Limited | 536.39 Million INR | 53.414% |
| OXYGENTA PHARMACEUTICAL LIMITE | 833.14 Million INR | 70.007% |
| Ambalal Sarabhai Enterprises Limited | 1.13 Billion INR | 77.904% |
| Gennex Laboratories Limited | 535.21 Million INR | 53.311% |
| Denis Chem Lab Limited | 289.82 Million INR | 13.779% |
| Colinz Laboratories Limited | 24.1 Million INR | -936.656% |
| Godavari Drugs Limited | 957.86 Million INR | 73.912% |
| Zenotech Laboratories Limited | 156.64 Million INR | -59.521% |
| Shree Ganesh Remedies Limited | 488.36 Million INR | 48.832% |
| Bharat Parenterals Limited | 2.65 Billion INR | 90.593% |
| Coral Laboratories Limited | 281.83 Million INR | 11.337% |
| Evoq Remedies Limited | 116.23 Million INR | -114.989% |
| Kerala Ayurveda Limited | 1.05 Billion INR | 76.373% |
| KOBO BIOTECH LIMITED | 2.04 Billion INR | 87.769% |
| Natural Capsules Limited | 1.47 Billion INR | 83.084% |
| Auro Laboratories Limited | 433.09 Million INR | 42.303% |